HomeRPTX • NASDAQ
Repare Therapeutics Inc
add
$1.12
0.88%
Pre-market:(0.89%)+0.0100
$1.13
Closed: Mar 14, 12:30:56 AM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 108.86M | -15.61% |
Net income | -28.67M | -2.29% |
Net profit margin | — | — |
Earnings per share | -0.68 | -1.18% |
EBITDA | -30.34M | 0.06% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 152.79M | -31.68% |
Total assets | 176.51M | -30.48% |
Total liabilities | 25.38M | -39.32% |
Total equity | 151.13M | — |
Shares outstanding | 42.51M | — |
Price to book | 0.32 | — |
Return on assets | -40.21% | — |
Return on capital | -46.58% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -28.67M | -2.29% |
Cash from operations | -27.32M | 2.95% |
Cash from investing | 31.59M | -0.92% |
Cash from financing | 1.00K | -99.05% |
Net change in cash | 4.18M | 7.10% |
Free cash flow | -16.69M | 6.38% |
Previous close
$1.13
Day range
$1.09 - $1.17
Year range
$1.06 - $5.66
Market cap
47.61M USD
Avg Volume
205.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Website
Employees
129